Sanofi

ELITEK

Manufacturer:

Sanofi

Elitek HCPCS:

J2783

HCPCS Code Descriptor:

Injection, rasburicase, 0.5 mg

Category:

J Code

Elitek NDCs:

00024-5151-75, 00024-5150-10

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Elitek:

ELITEK is an Oncology drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J2783 is aligned to the drug ELITEK.

ACCESS PRICING AND MORE BY REGISTERING

J2783 Added Date:

January 1, 2004

J2783 Effective Date:

January 1, 2004

J2783 Termination Date:

HCPCS Active

Elitek billing and coding information can be found through Sanofi at the link below:
Elitek patient assistance information can be found through Sanofi’s CareASSIST at the URL: https://www.sanoficareassist.com/
ELITEK prescribing information can be found at the link below:
Information regarding ELITEK’s side effects can be found at MedlinePlus